Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis

被引:4
|
作者
Enkui Hao
Partha Mukhopadhyay
Zongxian Cao
Katalin Erdélyi
Eileen Holovac
Lucas Liaudet
Wen-Shin Lee
György Haskó
Raphael Mechoulam
Pál Pacher
机构
[1] National Institutes of Health,Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism
[2] Shandong University,Department of Cardiology, Shandong Provincial Qianfoshan Hospital
[3] BH 08-621 University Hospital Medical Center,Department of Intensive Care Medicine
[4] National Yang-Ming University School of Medicine,Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital
[5] Rutgers New Jersey Medical School,Departments of Surgery
[6] Hebrew University of Jerusalem,Department for Medicinal Chemistry and Natural Products, Faculty of Medicine
[7] National Institutes of Health/NIAAA,Section on Oxidative Stress Tissue Injury, Laboratory of Physiological Studies
来源
Molecular Medicine | 2015年 / 21卷
关键词
Cannabidiol (CBD); Nitrative Stress; Estrogen-related Receptor Alpha; Mitochondrial Copy Number; Poly (ADP-ribose) Polymerase (PARP);
D O I
暂无
中图分类号
学科分类号
摘要
Doxorubicin (DOX) is a widely used, potent chemotherapeutic agent; however, its clinical application is limited because of its dose-dependent cardiotoxicity. DOX’s cardiotoxicity involves increased oxidative/nitrative stress, impaired mitochondrial function in cardiomyocytes/endothelial cells and cell death. Cannabidiol (CBD) is a nonpsychotropic constituent of marijuana, which is well tolerated in humans, with antioxidant, antiinflammatory and recently discovered antitumor properties. We aimed to explore the effects of CBD in a well-established mouse model of DOX-induced cardiomyopathy. DOX-induced cardiomyopathy was characterized by increased myocardial injury (elevated serum creatine kinase and lactate dehydrogenase levels), myocardial oxidative and nitrative stress (decreased total glutathione content and glutathione peroxidase 1 activity, increased lipid peroxidation, 3-nitrotyrosine formation and expression of inducible nitric oxide synthase mRNA), myocardial cell death (apoptotic and poly(ADP)-ribose polymerase 1 (PARP)-dependent) and cardiac dysfunction (decline in ejection fraction and left ventricular fractional shortening). DOX also impaired myocardial mitochondrial biogenesis (decreased mitochondrial copy number, mRNA expression of peroxisome proliferator-activated receptor γ coactivator 1-alpha, peroxisome proliferator-activated receptor alpha, estrogen-related receptor alpha), reduced mitochondrial function (attenuated complex I and II activities) and decreased myocardial expression of uncoupling protein 2 and 3 and medium-chain acyl-CoA dehydrogenase mRNA. Treatment with CBD markedly improved DOX-induced cardiac dysfunction, oxidative/nitrative stress and cell death. CBD also enhanced the DOX-induced impaired cardiac mitochondrial function and biogenesis. These data suggest that CBD may represent a novel cardioprotective strategy against DOX-induced cardiotoxicity, and the above-described effects on mitochondrial function and biogenesis may contribute to its beneficial properties described in numerous other models of tissue injury.
引用
收藏
页码:38 / 45
页数:7
相关论文
共 50 条
  • [1] Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
    Hao, Enkui
    Mukhopadhyay, Partha
    Cao, Zongxian
    Erdelyi, Katalin
    Holovac, Eileen
    Liaudet, Lucas
    Lee, Wen-Shin
    Hasko, Gyoergy
    Mechoulam, Raphael
    Pacher, Pal
    MOLECULAR MEDICINE, 2015, 21 : 38 - 45
  • [2] Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy
    Santos, DL
    Moreno, AJM
    Leino, RL
    Froberg, MK
    Wallace, KB
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 185 (03) : 218 - 227
  • [3] Promoting Mitochondrial Biogenesis Protects against Doxorubicin-Induced Cardiomyocyte Injury
    Uche, Nuamdi
    Lai, Shupin
    Dai, Qiang
    Benjamin, Ivor
    FASEB JOURNAL, 2022, 36
  • [4] Dietary Nitrate Supplementation Protects Against Doxorubicin-Induced Cardiomyopathy by Improving Mitochondrial Function
    Zhu, Shu-Guang
    Kukreja, Rakesh C.
    Das, Anindita
    Chen, Qun
    Lesnefsky, Edward J.
    Xi, Lei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (21) : 2181 - 2189
  • [5] Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
    Liu, Yan
    Asnani, Aarti
    Zou, Lin
    Bentley, Victoria L.
    Yu, Min
    Wang, You
    Dellaire, Graham
    Sarkar, Kumar S.
    Dai, Matthew
    Chen, Howard H.
    Sosnovik, David E.
    Shin, Jordan T.
    Haber, Daniel A.
    Berman, Jason N.
    Chao, Wei
    Peterson, Randall T.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (266)
  • [6] SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
    Wang, Panxia
    Wang, Luping
    Lu, Jing
    Hu, Yuehuai
    Wang, Qianqian
    Li, Zhenzhen
    Cai, Sidong
    Liang, Liying
    Guo, Kaiteng
    Xie, Jiyan
    Wang, Junjian
    Lan, Rui
    Shen, Juan
    Liu, Peiqing
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 133 : 125 - 137
  • [7] An activator of GPX4 protects against doxorubicin-induced cardiomyopathy
    Huang, C.
    Wang, L.
    Sun, G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1310 - S1310
  • [8] Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
    Wallace, Kendall B.
    Sardao, Vilma A.
    Oliveira, Paulo J.
    CIRCULATION RESEARCH, 2020, 126 (07) : 926 - 941
  • [9] Deletion of LOX-1 protects against doxorubicin-induced cardiomyopathy
    Yokoyama, C.
    Aoyama, T.
    Shiraki, T.
    Hayakawa, Y.
    Takeyama, T.
    Nishigaki, K.
    Fujiwara, T.
    Fujiwara, H.
    Sawamura, T.
    Minatoguchi, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 1096 - 1096
  • [10] Adiponectin Protects Doxorubicin-induced Cardiomyopathy in Mice
    Konishi, Masanori
    Haraguchi, Go
    Ishihara, Takashi
    Ohigashi, Hirokazu
    Saito, Kiyomi
    Nakano, Yasuko
    Isobe, Mitsuaki
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 : S34 - S34